IISc Develops Low-Cost Artificial Pancreas for India
Recently, researchers at the Indian Institute of Science developed a groundbreaking platform to improve diabetes management across India. This initiative specifically leverages advanced artificial pancreas technology to make clinical management more affordable for patients. Consequently, the project aims to bridge the huge gap in accessibility for millions of individuals who require specialized diabetes care.
The Promise of Artificial Pancreas Technology
Specifically, Prof Radhakant Padhi and his dedicated team are leading this remarkable technological development. Furthermore, their innovative platform, SugarSight, effectively monitors and predicts blood glucose shifts in real time. In addition, this system integrates an electronic sensor, a control algorithm, and a precise insulin pump. Therefore, it closely mimics the natural physiological functions of a healthy human pancreas.
Making Advanced Diabetes Care Affordable
Currently, commercial imported devices cost patients up to six lakh rupees. However, the Indian Institute of Science team plans to offer their indigenous system for just two lakh rupees. Consequently, this massive price reduction will definitely help lower-income groups obtain better care. Meanwhile, the researchers are redeveloping the current prototype to satisfy strict medical device regulatory standards, ensuring that future diabetes and metabolic disorder care can be delivered more efficiently to the masses.
Frequently Asked Questions
Q1: What is the primary benefit of the SugarSight platform?
The platform analyses blood glucose readings, meal intake, physical activity, and insulin sensitivity to provide personalised insulin recommendations. Furthermore, it predicts blood sugar trends to prevent dangerous episodes.
Q2: How much will the new indigenous artificial pancreas cost?
The team aims to launch the complete system at a target cost of approximately two lakh rupees. Consequently, this makes it significantly cheaper than commercial alternatives that cost around six lakh rupees for those seeking advanced endocrinology solutions.
References
- IISc develops AI platform, eyes affordable artificial pancreas for diabetes care – ETHealthworld
- Smartphone linked artificial pancreas for type-1 diabetes – Indian Institute of Science
- Bengaluru’s IISc team develops indigenous AI-powered diabetes-care system – Times of India
Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.
